Home » Topics » BioWorld Science

BioWorld Science
RSS

Patient enrollment ongoing in phase II study of BCD-089

March 16, 2018

Positive topline data from phase III study of ALXN-1210 in patients with PNH

March 16, 2018

Zymeworks to advance ZW-49 bispecific ADC

March 16, 2018

FDA grants orphan drug designation to Proteostasis Therapeutics' PTI-428

March 16, 2018

Novel AC5 inhibitor for treating myocardial infarction shows promise

March 15, 2018

Exosome Diagnostics collaborates with Intezyne on assay for use in IT-139 trials

March 15, 2018

3M Innovative Properties cytokine-production inducers

March 15, 2018

University of Michigan discovers Bcr-Abl kinase inhibitors

March 15, 2018

FDA awards fast track designation to Destiny Pharma's exeporfinium chloride

March 15, 2018

Japanese researchers disclose PDE7 inhibitors

March 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...